| Product Code: ETC9554660 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Fabry Disease Drug Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Fabry Disease Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Fabry Disease Drug Market - Industry Life Cycle |
3.4 Sweden Fabry Disease Drug Market - Porter's Five Forces |
3.5 Sweden Fabry Disease Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sweden Fabry Disease Drug Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Sweden Fabry Disease Drug Market Revenues & Volume Share, By End- User, 2021 & 2031F |
4 Sweden Fabry Disease Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Fabry disease in Sweden |
4.2.2 Growing awareness and diagnosis rates of Fabry disease |
4.2.3 Advances in research and development of Fabry disease treatments |
4.3 Market Restraints |
4.3.1 High cost associated with Fabry disease drugs |
4.3.2 Limited availability of approved treatments for Fabry disease in Sweden |
5 Sweden Fabry Disease Drug Market Trends |
6 Sweden Fabry Disease Drug Market, By Types |
6.1 Sweden Fabry Disease Drug Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Fabry Disease Drug Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Sweden Fabry Disease Drug Market Revenues & Volume, By Classic Fabry Disease, 2021- 2031F |
6.1.4 Sweden Fabry Disease Drug Market Revenues & Volume, By Atypical Late-Onset Fabry Disease, 2021- 2031F |
6.2 Sweden Fabry Disease Drug Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Sweden Fabry Disease Drug Market Revenues & Volume, By Enzyme Replacement Therapy, 2021- 2031F |
6.2.3 Sweden Fabry Disease Drug Market Revenues & Volume, By Chaperone Treatment, 2021- 2031F |
6.2.4 Sweden Fabry Disease Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sweden Fabry Disease Drug Market, By End- User |
6.3.1 Overview and Analysis |
6.3.2 Sweden Fabry Disease Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Sweden Fabry Disease Drug Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Sweden Fabry Disease Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.5 Sweden Fabry Disease Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Fabry Disease Drug Market Import-Export Trade Statistics |
7.1 Sweden Fabry Disease Drug Market Export to Major Countries |
7.2 Sweden Fabry Disease Drug Market Imports from Major Countries |
8 Sweden Fabry Disease Drug Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for Fabry disease drugs |
8.2 Adoption rate of new Fabry disease treatments in Sweden |
8.3 Number of healthcare providers specializing in Fabry disease management |
9 Sweden Fabry Disease Drug Market - Opportunity Assessment |
9.1 Sweden Fabry Disease Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sweden Fabry Disease Drug Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Sweden Fabry Disease Drug Market Opportunity Assessment, By End- User, 2021 & 2031F |
10 Sweden Fabry Disease Drug Market - Competitive Landscape |
10.1 Sweden Fabry Disease Drug Market Revenue Share, By Companies, 2024 |
10.2 Sweden Fabry Disease Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here